KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $364 | -100.0% | 272 | -100.0% | 0.00% | -100.0% |
Q4 2022 | $6,771,484 | +35539.4% | 1,991,613 | +56803.2% | 0.02% | – |
Q3 2022 | $19,000 | -99.6% | 3,500 | -99.0% | 0.00% | -100.0% |
Q3 2020 | $5,106,000 | -67.2% | 349,723 | -86.5% | 0.03% | -67.9% |
Q2 2019 | $15,552,000 | +7.7% | 2,596,323 | +68.4% | 0.08% | +14.1% |
Q4 2018 | $14,446,000 | -10.8% | 1,541,718 | +62.2% | 0.07% | +6.0% |
Q3 2018 | $16,187,000 | -33.9% | 950,493 | -34.1% | 0.07% | -31.6% |
Q2 2018 | $24,503,000 | -6.8% | 1,442,183 | -26.4% | 0.10% | -10.9% |
Q1 2018 | $26,283,000 | -18.3% | 1,958,527 | -41.6% | 0.11% | -20.9% |
Q4 2017 | $32,179,000 | +2236.9% | 3,351,996 | +8407.6% | 0.14% | +1290.0% |
Q3 2014 | $1,377,000 | +270.2% | 39,400 | +392.5% | 0.01% | +400.0% |
Q2 2014 | $372,000 | – | 8,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |